News for 'US Generics'

Infosys, L&T are top picks of most brokerages for Samvat 2078

Infosys, L&T are top picks of most brokerages for Samvat 2078

Rediff.com12 Nov 2021

Despite unprecedented levels of uncertainty in Samvat 2077, investors have little to complain about on the returns front. The BSE Sensex delivered returns of 38 per cent in this period, while the Nifty registered a return of over 40 per cent. As is the case in bull markets, companies in the small- and mid-capitalisation basket outperformed the benchmarks, with returns almost twice those of frontliners.

1st uncrewed mission of Gaganyaan not possible in Dec: ISRO

1st uncrewed mission of Gaganyaan not possible in Dec: ISRO

Rediff.com26 Jul 2021

According to sources in the Bengaluru-headquartered space agency, under the Department of Space, delivery of hardware by the industry was hit due to the lockdown imposed in several States to contain the pandemic in recent months.

Pill for thought: Sweetheart deals that hurt consumers

Pill for thought: Sweetheart deals that hurt consumers

Rediff.com16 Sep 2014

'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators

Modi meets Bill Gates; discusses climate change

Modi meets Bill Gates; discusses climate change

Rediff.com2 Nov 2021

Prime Minister Narendra Modi on Tuesday met Microsoft co-founder and billionaire philanthropist Bill Gates on the sidelines of the climate summit here and discussed ways to further sustainable development, steps to mitigate climate change and vaccine research. The meeting between Modi and the American business magnate, whose foundation is focusing on fighting the COVID-19 pandemic, took place after the former launched the Initiative for the Resilient Island States (IRIS) for developing infrastructure of small island nations. Prime Minister Modi expressed appreciation for the work being done by the Bill and Melinda Gates Foundation in India, the Ministry of External Affairs (MEA) said in a statement.

Soon, regular yoga will get you a discount on your insurance premium

Soon, regular yoga will get you a discount on your insurance premium

Rediff.com1 Nov 2021

The Insurance Regulatory Development Authority of India (Irdai), the regulator for insurance companies, is set to allow the insurers to offer wellness programmes along with life insurance policies that can earn reward points for the policyholders. These reward points can be redeemed for getting a discount during renewal. The insurance regulator has circulated draft guidelines to insurance companies for feedback before issuing the final guidelines, as is the norm.

Plea in HC against allowing same sex marriage under Hindu Marriage Act

Plea in HC against allowing same sex marriage under Hindu Marriage Act

Rediff.com3 Dec 2021

The plea argued that any changes such as inclusion of same sex marriage in the Customary Law are much easier, convenient and practical in marriages which are a type of contract between the partners as they are very remotely based on religion and more generic in nature.

Govt issues revised guidelines for home isolation

Govt issues revised guidelines for home isolation

Rediff.com5 Jan 2022

It also advised people not to rush for self-medication, blood investigation or radiological imaging like chest X-ray or CT scan without consultation of treating medical officer.

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.

The Great Railway Station Makeover

The Great Railway Station Makeover

Rediff.com6 Jul 2021

The Indian Railway Station Development Corporation is now looking to modernise 90 stations across the country.

IPO frenzy continues; 2 public issues to open on Sep 1

IPO frenzy continues; 2 public issues to open on Sep 1

Rediff.com29 Aug 2021

The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.

'Profiting from Pain': Covid created new billionaire every 30 hrs

'Profiting from Pain': Covid created new billionaire every 30 hrs

Rediff.com23 May 2022

Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.

Nothing Surprising About Agnipath

Nothing Surprising About Agnipath

Rediff.com11 Jul 2022

Agnipath may be an exercise to address the genuine needs of the armed forces. But overall, it betrays the tendency to use the military and paramilitary for employment generation and shaping a national character, instead of treating them as the professional services they are, notes Shyam G Menon.

Thallumaala Won't Let You Breathe Or Blink

Thallumaala Won't Let You Breathe Or Blink

Rediff.com19 Aug 2022

Friendships are not merely severed, but built over scuffles. And just about anything can stir things up -- a long-standing feud, a pointless stare, a disrupted moral stance, a fist that ricochets off a face and smacks another face in the near vicinity, observes Sreehari Nair.

Cancer drug prices highest in US, treatment expensive in India

Cancer drug prices highest in US, treatment expensive in India

Rediff.com6 Jun 2016

The lowest drug prices were found in India and South Africa.

ISRO races against time for 1st uncrewed mission of Gaganyaan

ISRO races against time for 1st uncrewed mission of Gaganyaan

Rediff.com28 Jun 2021

Officials of the Bengaluru-headquartered space agency said the first and second waves of the pandemic have "severely affected" the Gaganyaan programme.

Warne slammed for racial slur at Pujara

Warne slammed for racial slur at Pujara

Rediff.com18 Dec 2020

'Shane Warne is sick. He was an incredible cricketer but his lack of sensitivity & ignorance on a lot of occasions is baffling.'

European Commission fines 9 pharma firms, including Ranbaxy

European Commission fines 9 pharma firms, including Ranbaxy

Rediff.com19 Jun 2013

According to information available on the European Commission website, Ranbaxy Laboratories has been fined euro 10.32 million (over Rs 80 crore).

Glenmark gets USFDA nod for skin infections cream

Glenmark gets USFDA nod for skin infections cream

Rediff.com30 Sep 2013

Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd has received nod for it's Hydrocortisone Butyrate Cream USP (0.1 per cent), abbreviated new drug approval from the United States Food and Drug Administration, Glenmark Pharmaceuticals said in a statement.

Less competition, demand-supply gap push US drug prices

Less competition, demand-supply gap push US drug prices

Rediff.com13 Oct 2014

Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

What exactly is wrong with India's pharma companies?

What exactly is wrong with India's pharma companies?

Rediff.com12 Sep 2017

Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation

India slams talk about Quad's 'limited agenda'

India slams talk about Quad's 'limited agenda'

Rediff.com15 Sep 2021

Remarks from Indian External Affairs are significant as it comes after China slammed Quad and said the formation of "exclusive cliques" targeting other countries runs counter to the trend of the times and is "doomed to fail".

'This movie has made China introspect and learn from India'

'This movie has made China introspect and learn from India'

Rediff.com21 Jul 2018

Dying To Survive, on its way to becoming China's biggest box office hit, may compel the Xi Jinping government to change its policy towards Indian pharmaceutical companies, says Tarun Vijay.

How Modi, Xi can tackle the worrying trade deficit

How Modi, Xi can tackle the worrying trade deficit

Rediff.com11 Oct 2019

'Since the bilateral deficit is a reality -- and a worry -- we need to find a way to deal with it,' says Ravi Bhoothalingam.

New To Crypto Investing? 7 Tips For You

New To Crypto Investing? 7 Tips For You

Rediff.com11 Feb 2022

Avoid thinking of investment as some 'become millionaire in a week' scheme, says Nikhil Sethi, founder and MD, Zuvomo, a crowdfunding firm. Always think of long term gains and plan your trades accordingly.

2022: How Will The Markets Behave?

2022: How Will The Markets Behave?

Rediff.com1 Jan 2022

Will 2022 be a year of contrasting narratives -- one filled with caution and the other with continued optimism?

Prices of key diabetes, cancer drugs may drop by 25%

Prices of key diabetes, cancer drugs may drop by 25%

Rediff.com8 Mar 2018

A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.

Sun Pharma settles litigation with Novartis over cancer drug

Sun Pharma settles litigation with Novartis over cancer drug

Rediff.com15 May 2014

One of the subsidiaries of Sun Pharma has executed a settlement agreement with Novartis, stipulating a dismissal of the lawsuits filed in the United States against the company regarding submission of an Abbreviated New Drug Application for a generic version of Gleevec, the Indian drug major said in a statement.

Watson sends patent challenge notice to Ranbaxy for acne drug

Watson sends patent challenge notice to Ranbaxy for acne drug

Rediff.com20 Sep 2013

The drug is licensed to Ranbaxy Laboratories from Cipher Pharmaceuticals Inc of Mississauga, Ontario. It is currently protected by two issued patents listed in the FDA's approved drug products list, which expire in September 2021, the company said in a statement.

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Rediff.com16 Apr 2014

Sunovion Pharmaceuticals Inc is the owner of the Eszopiclone drug.

Banks not to make any dividend payment for FY20; told to retain profit

Banks not to make any dividend payment for FY20; told to retain profit

Rediff.com4 Dec 2020

In view of the economic shock caused by the COVID-19 pandemic, Reserve Bank of India (RBI) on Friday asked scheduled commercial banks and co-operative banks not to make any dividends for the financial year ended March 2020. In view of the ongoing stress and the heightened uncertainty on account of the pandemic, RBI said it is imperative that banks continue to conserve capital to support the economy and absorb losses, if any. The decision is based on review of the September quarter financial performance of banks.

US regulator tightens drug approval norms

US regulator tightens drug approval norms

Rediff.com29 Jul 2013

Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics

Approval delays to hurt Indian pharma cos' US sales

Approval delays to hurt Indian pharma cos' US sales

Rediff.com13 Nov 2014

Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.

10 stocks that FPIs bought and sold the most

10 stocks that FPIs bought and sold the most

Rediff.com12 May 2022

The FPI holding in India's top 100 companies, which are part of the Nifty 100 index, declined to 24.23 per cent on average at the end of March this year, from a high of 27.5 per cent at the end of March 2021. This is the lowest FPI holdings in India's top listed companies in at least three years. A general sell-off by FPIs has weighed on stock prices and the benchmark S&P BSE Sensex is down 8.5 per cent, from its 52-week high made in October 2021. Most analysts expect FPI flows to remain weak in FY23 as well, given rising bond yields in the US and an expected earnings slowdown in India due to high inflation and commodity prices.

When Bollywood danced in a FIELD OF GOLD

When Bollywood danced in a FIELD OF GOLD

Rediff.com8 Feb 2021

Sukanya Verma looks at mustard field memories of Bollywood.

Why Designing Clothes For This Film Was SO TOUGH!

Why Designing Clothes For This Film Was SO TOUGH!

Rediff.com8 Mar 2022

'Kangana is such a stylo, she knows what will look good on her.'

Want to invest in Healthcare ETFs?

Want to invest in Healthcare ETFs?

Rediff.com4 Jun 2021

If a retail investor wants exposure to a healthcare ETF, it should be a part of his satellite portfolio, suggests Sanjay Kumar Singh.

5 things to AVOID in a cover letter

5 things to AVOID in a cover letter

Rediff.com8 Apr 2021

Your cover letter length should not exceed one page and 250 to 300 words, advises Sarvesh Agrawal.

Ranbaxy's high on Lipitor to go on in US

Ranbaxy's high on Lipitor to go on in US

Rediff.com12 Jun 2012

The upside for Ranbaxy Laboratories is likely to continue even as it loses its 180 days of marketing exclusivity for the Lipitor generic in the American market.

'I am a switch on-switch off actor'

'I am a switch on-switch off actor'

Rediff.com19 Aug 2021

'I don't let it affect my life because otherwise, we will go mad.'